9-130450341-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_054012.4(ASS1):c.-5-1883C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00251 in 987,336 control chromosomes in the GnomAD database, including 38 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.010 ( 26 hom., cov: 33)
Exomes 𝑓: 0.0011 ( 12 hom. )
Consequence
ASS1
NM_054012.4 intron
NM_054012.4 intron
Scores
2
Splicing: ADA: 0.00001812
2
Clinical Significance
Conservation
PhyloP100: 0.296
Genes affected
ASS1 (HGNC:758): (argininosuccinate synthase 1) The protein encoded by this gene catalyzes the penultimate step of the arginine biosynthetic pathway. There are approximately 10 to 14 copies of this gene including the pseudogenes scattered across the human genome, among which the one located on chromosome 9 appears to be the only functional gene for argininosuccinate synthetase. Mutations in the chromosome 9 copy of this gene cause citrullinemia. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Aug 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 9-130450341-C-T is Benign according to our data. Variant chr9-130450341-C-T is described in ClinVar as [Benign]. Clinvar id is 381450.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0101 (1532/152318) while in subpopulation AFR AF= 0.0346 (1437/41562). AF 95% confidence interval is 0.0331. There are 26 homozygotes in gnomad4. There are 730 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 26 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ASS1 | NM_054012.4 | c.-5-1883C>T | intron_variant | ENST00000352480.10 | |||
ASS1 | NM_000050.4 | c.-6+8C>T | splice_region_variant, intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ASS1 | ENST00000352480.10 | c.-5-1883C>T | intron_variant | 1 | NM_054012.4 | P1 | |||
ASS1 | ENST00000372393.7 | c.-6+8C>T | splice_region_variant, intron_variant | 5 | P1 | ||||
ASS1 | ENST00000372394.5 | c.-447-1261C>T | intron_variant | 2 | P1 | ||||
ASS1 | ENST00000422569.5 | c.-5-1883C>T | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0100 AC: 1529AN: 152200Hom.: 26 Cov.: 33
GnomAD3 genomes
AF:
AC:
1529
AN:
152200
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00114 AC: 951AN: 835018Hom.: 12 Cov.: 29 AF XY: 0.00107 AC XY: 413AN XY: 385746
GnomAD4 exome
AF:
AC:
951
AN:
835018
Hom.:
Cov.:
29
AF XY:
AC XY:
413
AN XY:
385746
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0101 AC: 1532AN: 152318Hom.: 26 Cov.: 33 AF XY: 0.00980 AC XY: 730AN XY: 74480
GnomAD4 genome
AF:
AC:
1532
AN:
152318
Hom.:
Cov.:
33
AF XY:
AC XY:
730
AN XY:
74480
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 10, 2015 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Citrullinemia type I Benign:1
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | Apr 09, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at